Influence of atrial natriuretic peptide, brain natriuretic peptide and urodilatin on the histamine-induced bronchoconstriction in the conscious guinea pig.
The influence of human atrial natriuretic peptide (ANP) and of two related peptides, human brain natriuretic peptide (BNP) and urodilatin (URO) on the bronchoconstriction induced by inhalation of histamine in conscious, non-anaesthetized guinea pigs was tested.Changes in lung function were registered using two independent methods, one operating in a closed body-plethysmographic system, the other in an open system based on the time lag of air flow curves. The peptides were infused (0.25 ml/min) into the jugular vein for a period from 10 min before until 15 min after the histamine inhalation.ANP displayed virtually no effect on the bronchoconstriction. URO showed some inibition at 1280ng kg(-1) min(-1), but not at lower doses. BNP (640ng kg(-1) min(-1)) inhibited the bronchoconstriction markedly for the total registration period.It can be concluded from these results that BNP exerts bronchoprotective effects in the conscious guinea pig, which are superior to those of ANP or URO.
Hermel
M
M
Institute of Pharmacology and Toxicology at the RWTH Aachen, Wendlingweg, 52049, Aachen, Germany.
J Pharmacol Exp Ther. 1986 Feb;236(2):416-8
2935624
BMJ. 1989 Oct 28;299(6707):1081-2
2531618
J Appl Physiol Respir Environ Exerc Physiol. 1979 Feb;46(2):399-406
422457
Am J Physiol. 1986 Apr;250(4 Pt 2):F710-4
2938484
Am J Physiol. 1989 Feb;256(2 Pt 2):R469-75
2537040
Eur J Pharmacol. 1986 Jan 29;120(3):345-9
2936614
J Appl Physiol (1985). 1993 Dec;75(6):2353-9
7907323
J Pharmacol Exp Ther. 1986 Nov;239(2):474-9
2945922
Endocrinology. 1992 Jan;130(1):229-39
1309330
Pulm Pharmacol. 1988;1(3):119-23
2980981
Am Rev Respir Dis. 1992 Oct;146(4):912-5
1416418
Regul Pept. 1995 Nov 10;59(3):357-70
8577941
Science. 1983 Jul 1;221(4605):71-3
6857267
Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):778-82
1826192
Proc Natl Acad Sci U S A. 1984 May;81(9):2640-4
6232612
J Appl Physiol Respir Environ Exerc Physiol. 1979 Feb;46(2):346-53
422452
Clin Exp Pharmacol Physiol. 1993 Apr;20(4):239-43
8387413
Biochem Biophys Res Commun. 1989 Aug 30;163(1):226-32
2673236
Can J Physiol Pharmacol. 1991 Oct;69(10):1500-6
1723349
Science. 1987 Oct 30;238(4827):675-8
2823385
Int Arch Allergy Appl Immunol. 1983;71(2):131-6
6840870
Arzneimittelforschung. 1992 Nov;42(11):1329-31
1337250
Biochem Biophys Res Commun. 1988 Sep 15;155(2):740-6
3421966
Miner Electrolyte Metab. 1986;12(5-6):371-4
2949138
FEBS Lett. 1990 Jan 1;259(2):341-5
2136732
Biochem Biophys Res Commun. 1989 Jan 31;158(2):360-8
2521788
Eur J Pharmacol. 1988 Jun 10;150(3):397-400
2970976
Clin Exp Allergy. 1994 Aug;24(8):784-8
7982129
Nature. 1963 Jan 5;197:54-6
13980583
Klin Wochenschr. 1988 Sep 1;66(17):752-9
2972874
Biochem Biophys Res Commun. 1986 Sep 30;139(3):1215-23
2945560
Annu Rev Biochem. 1991;60:229-55
1652921
Am J Physiol. 1989 Mar;256(3 Pt 1):C495-500
2466407
Neuroendocrinology. 1985 Mar;40(3):277-9
3157876
J Appl Physiol (1985). 1990 Aug;69(2):728-33
2146244
J Clin Endocrinol Metab. 1990 Apr;70(4):1103-7
2156886
Biochem Biophys Res Commun. 1988 Sep 15;155(2):726-32
3421965
FEBS Lett. 1988 Jun 20;233(2):249-54
2968281
Pulm Pharmacol. 1991;4(2):120-5
1839511
Am Rev Respir Dis. 1988 Mar;137(3):548-57
3345037
Neuropeptides. 1990 Sep;17(1):1-5
2148814
Respir Physiol. 1975 Jul;24(2):191-202
1179048
Am J Physiol. 1958 Feb;192(2):364-8
13508884
Eur Respir J. 1994 Sep;7(9):1593-7
7995386
Nature. 1987 Apr 16-22;326(6114):697-8
2951600
Clin Sci (Lond). 1990 Jul;79(1):51-5
2167791
Am Rev Respir Dis. 1993 May;147(5):1122-5
8387254
Can J Physiol Pharmacol. 1990 Sep;68(9):1292-7
2148906
J Pharmacol Exp Ther. 1972 Jan;180(1):98-109
5010419
Hypertension. 1988 Oct;12(4):462-7
2971619
FEBS Lett. 1989 Jul 3;250(2):235-7
2526749
Biochem Biophys Res Commun. 1988 Nov 30;157(1):402-9
3196347
J Appl Physiol Respir Environ Exerc Physiol. 1982 Nov;53(5):1071-9
7174401
Peptides. 1986 Mar-Apr;7(2):241-6
2942845
Eur J Pharmacol. 1991 Sep 4;202(1):73-9
1664804
J Appl Physiol Respir Environ Exerc Physiol. 1980 Jun;48(6):1052-9
7380702
Prog Biochem Pharmacol. 1988;23:136-41
2847186
Nature. 1988 Mar 3;332(6159):78-81
2964562
Respir Physiol. 1981 Jan;43(1):23-30
7244424
Biochem Biophys Res Commun. 1990 Dec 14;173(2):599-605
2260971
Neuropeptides. 1989 Oct;14(3):161-9
2559355
J Appl Physiol. 1976 Jun;40(6):889-94
931927
Eur J Clin Pharmacol. 1986;31(1):101-3
2946587
Life Sci. 1981 Jan 5;28(1):89-94
7219045
J Clin Invest. 1991 Apr;87(4):1402-12
1849149
Eur J Clin Invest. 1995 Oct;25(10):728-36
8557059
BMJ. 1992 May 2;304(6835):1156
1392795
J Biol Chem. 1988 Dec 15;263(35):18827-33
2848808
Eur J Pharmacol. 1986 Feb 11;121(1):151-5
2937645
Br J Pharmacol. 1970 Aug;39(4):724-31
5485147
J Appl Physiol (1985). 1987 Oct;63(4):1572-7
3693194
Clin Investig. 1994 Oct;72(10):772-4
7865980
Eur J Clin Invest. 1992 Oct;22(10):662-9
1333960
Br J Pharmacol. 1988 Jul;94(3):938-46
3179617
Am J Physiol. 1970 Feb;218(2):596-9
5412481
J Clin Endocrinol Metab. 1993 Jan;76(1):91-6
8380606
Peptides. 1985 Jul-Aug;6(4):597-601
2933640
Life Sci. 1986 May 19;38(20):1827-33
2939312
Br J Pharmacol. 1993 Oct;110(2):804-8
8242254
J Biol Chem. 1988 Jul 5;263(19):9395-401
2837487
Biochem Biophys Res Commun. 1984 Jan 13;118(1):131-9
6230082
Arzneimittelforschung. 1990 Jul;40(7):771-6
1977395
Can J Physiol Pharmacol. 1989 Oct;67(10):1213-8
2532949
Biochem J. 1986 Dec 1;240(2):461-9
2949739
Am Rev Respir Dis. 1988 Jun;137(6):1323-5
3202371
Am J Physiol. 1990 Aug;259(2 Pt 2):F258-68
2167016
Biochem Biophys Res Commun. 1990 Mar 16;167(2):693-700
2138890
Eur J Pharmacol. 1984 Jun 15;102(1):169-73
6541140
Am J Physiol. 1987 May;252(5 Pt 1):E643-7
3034071
Biochem Biophys Res Commun. 1989 Aug 30;163(1):37-41
2570574
Mol Endocrinol. 1991 Sep;5(9):1292-300
1837590
Peptides. 1993 Nov-Dec;14(6):1325-30
8134314
Thorax. 1989 Feb;44(2):146-50
2929000
Biochem Biophys Res Commun. 1983 Dec 28;117(3):859-65
6230081
Am J Physiol. 1990 Nov;259(5 Pt 2):F832-8
2146885
Can J Physiol Pharmacol. 1990 Jan;68(1):131-6
2139352